Arcus Biosciences (RCUS) Operating Leases (2020 - 2022)
Arcus Biosciences (RCUS) posted quarterly Operating Leases of $119.2 million for Q3 2022, up 130.55% year-over-year from $51.7 million in Q3 2021, and down 1.77% quarter-over-quarter from $121.3 million in Q2 2022.
Arcus Biosciences (RCUS) Operating Leases (2020 - 2022) Analysis & Trends
Arcus Biosciences' Operating Leases history runs 3 years deep, the most recent figure standing at $119.2 million for Q3 2022.
- In Q3 2022, Operating Leases rose 130.55% year-over-year to $119.2 million; the TTM figure through Sep 2022 stood at $119.2 million (up 130.55% YoY), while the FY2021 annual figure was $116.9 million, up 666.82% from the prior year.
- Operating Leases for Q3 2022 stood at $119.2 million, down from $121.3 million in the prior quarter.
- The five-year high for Operating Leases was $121.3 million in Q2 2022, with the low at $14.7 million in Q1 2021.
- The 3-year median for Operating Leases is $83.5 million (2021), against an average of $75.8 million.
- Peak annual rise in Operating Leases reached 680.74% in 2022, while the deepest fall reached 130.55% in 2022.
- Arcus Biosciences' Operating Leases stood at $15.2 million in 2020, then soared by 666.82% to $116.9 million in 2021, then grew by 1.97% to $119.2 million in 2022.
- Business Quant data shows RCUS's Operating Leases at $119.2 million in Q3 2022, $121.3 million in Q2 2022, and $114.8 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 119.20 Mn |
| Jun 30, 2022 | 121.34 Mn |
| Mar 31, 2022 | 114.82 Mn |
| Dec 31, 2021 | 116.89 Mn |
| Sep 30, 2021 | 51.70 Mn |
| Jun 30, 2021 | 52.20 Mn |
| Mar 31, 2021 | 14.71 Mn |
| Dec 31, 2020 | 15.24 Mn |